Michael Erman
- Indexed articles, last 90 days
- 3
- Latest publication
- Aug 28, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Aug 18, 2026
Latest articles
Success After a Century Of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough (opens the original)
Read excerpt
Aug 28 (Reuters) - Stephane Bancel, CEO of Moderna, was at a Lebanese restaurant celebrating a friend’s birthday late on August 13 when he got the call. An mRNA cancer vaccine the company had been developing with Merck had hit its mark — the first success of a therapeutic cancer vaccine in late-stage testing after more than 100 years of failed attempts. Cancer experts hailed it as the beginning of an era of custom-made vaccines that train the immune system to fight an individual patient’s cance
Moderna, Merck Vaccine Cuts Recurrence and Spread Of Melanoma, Raising New Treatment Hope (opens the original)
Read excerpt
Aug 19 (Reuters) - Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment that sent Moderna's shares surging as much as 160%. The companies tested the vaccine together with Merck's immunotherapy drug Keytruda, a widely used melanoma treatment. Thousands of patients who have undergone surgery to remove high-risk melanoma tumors could benefit as soon
US Kindergarten Vaccine Coverage Continues Downward Trend, Falling 0.1% (opens the original)
Read excerpt
Aug 17 (Reuters) - U.S. kindergarten vaccination coverage fell 0.1% during the 2025-2026 school year, continuing a downward trend that has seen declines every year except one since the onset of COVID-19, according to data from the U.S. Centers for Disease Control and Prevention released on Monday. Coverage ranged from 92% for the diphtheria, tetanus and acellular pertussis vaccine (DTaP) to 92.4% for the measles, mumps and rubella vaccine (MMR) and the polio vaccine, the CDC said. The CDC said
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.